<?xml version="1.0" encoding="utf-8"?>
<Content Key="1319e8fb-e76e-4026-a37b-e1088c85bd19" Alias="SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement" Level="4">
  <Info>
    <Parent Key="4f317760-3810-44d3-ad6f-b6dc834b5bb4">News</Parent>
    <Path>/Homepage/NewsAndInsights/News/SHLMedicalAndLifecoreBiomedicalEnterCoMarketingPartnershipAgreement</Path>
    <Trashed>false</Trashed>
    <ContentType>pageNews</ContentType>
    <CreateDate>2024-12-09T10:41:41</CreateDate>
    <NodeName Default="SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement">
      <Name Culture="en-us">SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement</Name>
    </NodeName>
    <SortOrder>69</SortOrder>
    <Published Default="true">
      <Published Culture="en-us">true</Published>
    </Published>
    <Schedule />
    <Template Key="e9e10bc1-b033-4ae1-b176-fa33dd19151e">PageNews</Template>
  </Info>
  <Properties>
    <cardCategory>
      <Value Culture="en-us"><![CDATA[]]></Value>
    </cardCategory>
    <cardDescription>
      <Value Culture="en-us"><![CDATA[]]></Value>
    </cardDescription>
    <cardImage>
      <Value Culture="en-us"><![CDATA[[
  "{\"Id\":\"rgmfr39nb5z7s9cmx4n4nwr\",\"FileName\":\"SHL-Medical-and-Lifecore-Biomedical-enter-co-marketing-partnership-agreement_20231017_External-website.jpg\",\"Url\":\"https://cdn.bfldr.com/DTG6CG68/at/rgmfr39nb5z7s9cmx4n4nwr/SHL-Medical-and-Lifecore-Biomedical-enter-co-marketing-partnership-agreement_20231017_External-website.jpg\",\"AssetId\":\"k5nxh8k6f839ctzkxkf868t\",\"AssetName\":\"SHL-Medical-and-Lifecore-Biomedical-enter-co-marketing-partnership-agreement 20231017 External-website\",\"AssetDescription\":\"\"}"
]]]></Value>
    </cardImage>
    <contentBlocks>
      <Value Culture="en-us"><![CDATA[{
  "layout": {
    "Umbraco.BlockList": [
      {
        "contentUdi": "umb://element/a8e8de164f754eafa2303c0a2ffed001",
        "settingsUdi": "umb://element/7175b535e3684ed795b915a8946be4cd"
      },
      {
        "contentUdi": "umb://element/ece181052e7c41af946815f0356ec92b",
        "settingsUdi": "umb://element/9d8bcbafed864b5eabe4c08036ba5df1"
      }
    ]
  },
  "contentData": [
    {
      "contentTypeKey": "ecbe2af4-190e-4c73-886b-bff753532aa8",
      "udi": "umb://element/ece181052e7c41af946815f0356ec92b",
      "text": {
        "markup": "\n\n\n\n\n<p>SHL Medical (“SHL”), a world-leading solutions provider of advanced drug delivery systems such as autoinjectors and innovative specialty delivery systems, has entered into a non-exclusive co-marketing partnership agreement with Lifecore Biomedical (Nasdaq: LFCR) (“Lifecore”), a fully integrated Contract Development and Manufacturing Organization (“CDMO”) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials.</p>\n<p>Through this partnership, Lifecore becomes a member of SHL’s recently announced <a href=\"https://bit.ly/3Q2lnzA\">Alliance Management program</a>, an initiative created to further strengthen SHL’s vertically integrated business model by facilitating customer engagement with other key players within the drug delivery ecosystem.</p>\n<p>SHL and Lifecore will, pursuant to the terms of its agreement, exchange knowledge and experience in their respective fields, enabling both companies to provide their customers unparalleled guidance in CDMO services and best-in-class options for drug delivery device development.</p>\n<p>As the leader and pioneer of autoinjectors, SHL offers drug delivery device solutions and vertically integrated capabilities for the <a href=\"https://bit.ly/3QjwhSV\">development</a>, <a href=\"https://bit.ly/3ZXwRJm\">manufacturing</a>, and <a href=\"https://bit.ly/45Hot28\">final assembly</a> of its autoinjector products. The partnership with Lifecore will allow SHL to recommend a trusted CDMO renowned for its proven proficiency and robust quality systems in aseptic pharmaceutical manufacturing and primary container filling, creating a comprehensive support system across all stages of the autoinjector development and commercial lifecycle.</p>\n<p>“As a true partner to pharma and biotech, we believe in providing full end-to-end solutions that enhance patients’ quality of life and enable patients’ independence,” said Kimberlee Steele, Managing Director of SHL Pharma, SHL Medical’s final assembly, labeling, and packaging business unit in Florida. “We are excited to partner with Lifecore to provide high-quality CDMO services matching SHL’s own high-touch approach to servicing our customers.”</p>\n<p>Darren Hieber, Senior Vice President of Corporate Development and Partnerships for Lifecore commented, “We are continuously adapting to keep pace with the evolution of healthcare treatments and technologies and our deep expertise in the fill-finish of syringes and vials is a perfect match for SHL’s products. Our relationship with SHL will expand the breadth of our offerings to our CDMO customers, enabling them to deliver the benefits and convenience of innovative drug delivery systems to their patients worldwide. We are excited to be aligned with an industry leader, who has created a business focused on patient-centric solutions through their unique, convenient, high-quality product portfolio.”</p>\n<p> </p>\n\n\n\n<h2><span style=\"color: #000000;\"><strong>About Lifecore Biomedical</strong></span></h2>\n<p>Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of complex sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the Company, visit Lifecore’s website at <a href=\"http://www.lifecore.com/\" target=\"_blank\" rel=\"noopener noreferrer\">www.lifecore.com</a>.</p>\n",
        "blocks": {
          "contentData": [],
          "settingsData": []
        }
      },
      "textSize": "",
      "reduceMargin": "",
      "primaryLink": "",
      "secondLink": "",
      "showReadMoreOption": ""
    },
    {
      "contentTypeKey": "8681ee8c-079a-4d70-8dbd-d90a5018488e",
      "udi": "umb://element/a8e8de164f754eafa2303c0a2ffed001",
      "image": [
        "{\"Id\":\"rgmfr39nb5z7s9cmx4n4nwr\",\"FileName\":\"SHL-Medical-and-Lifecore-Biomedical-enter-co-marketing-partnership-agreement_20231017_External-website.jpg\",\"Url\":\"https://cdn.bfldr.com/DTG6CG68/at/rgmfr39nb5z7s9cmx4n4nwr/SHL-Medical-and-Lifecore-Biomedical-enter-co-marketing-partnership-agreement_20231017_External-website.jpg\",\"AssetId\":\"k5nxh8k6f839ctzkxkf868t\",\"AssetName\":\"SHL-Medical-and-Lifecore-Biomedical-enter-co-marketing-partnership-agreement 20231017 External-website\",\"AssetDescription\":\"\"}"
      ],
      "caption": "",
      "fullWidth": "0"
    }
  ],
  "settingsData": [
    {
      "contentTypeKey": "fecd61f2-eabe-438f-8cc0-5949254a80f6",
      "udi": "umb://element/9d8bcbafed864b5eabe4c08036ba5df1",
      "identifier": "",
      "navigationTitle": ""
    },
    {
      "contentTypeKey": "fecd61f2-eabe-438f-8cc0-5949254a80f6",
      "udi": "umb://element/7175b535e3684ed795b915a8946be4cd",
      "identifier": "",
      "navigationTitle": ""
    }
  ]
}]]></Value>
    </contentBlocks>
    <contentTags>
      <Value Culture="en-us"><![CDATA[[
  "SHL Medical"
]]]></Value>
    </contentTags>
    <date>
      <Value Culture="en-us"><![CDATA[2023-10-17T09:00:00]]></Value>
    </date>
    <doNotFollow>
      <Value Culture="en-us"><![CDATA[0]]></Value>
    </doNotFollow>
    <doNotIndex>
      <Value Culture="en-us"><![CDATA[0]]></Value>
    </doNotIndex>
    <hero>
      <Value Culture="en-us"><![CDATA[{
  "layout": {
    "Umbraco.BlockList": [
      {
        "contentUdi": "umb://element/677e2c12523a481eb0e04d0bb99043b7"
      }
    ]
  },
  "contentData": [
    {
      "contentTypeKey": "748d5c31-bf30-4ed4-8465-ca1252d29191",
      "udi": "umb://element/677e2c12523a481eb0e04d0bb99043b7",
      "title": "SHL Medical and Lifecore Biomedical enter co-marketing partnership agreement",
      "text": "",
      "subTitle": "",
      "primaryLink": "",
      "secondaryLink": ""
    }
  ],
  "settingsData": []
}]]></Value>
    </hero>
    <hideFromSearch>
      <Value Culture="en-us"><![CDATA[0]]></Value>
    </hideFromSearch>
    <pageTheme>
      <Value Culture="en-us"><![CDATA[{
  "value": "007cbe",
  "label": "light-blue",
  "sortOrder": 13,
  "id": "10"
}]]></Value>
    </pageTheme>
    <searchKeywords>
      <Value Culture="en-us"><![CDATA[]]></Value>
    </searchKeywords>
    <seoMetaDescription>
      <Value Culture="en-us"><![CDATA[]]></Value>
    </seoMetaDescription>
    <seoMetaTitle>
      <Value Culture="en-us"><![CDATA[]]></Value>
    </seoMetaTitle>
    <slogan>
      <Value Culture="en-us"><![CDATA[]]></Value>
    </slogan>
    <type>
      <Value Culture="en-us"><![CDATA[]]></Value>
    </type>
    <umbracoNaviHide>
      <Value Culture="en-us"><![CDATA[0]]></Value>
    </umbracoNaviHide>
    <umbracoUrlAlias>
      <Value Culture="en-us"><![CDATA[]]></Value>
    </umbracoUrlAlias>
    <umbracoUrlName>
      <Value Culture="en-us"><![CDATA[]]></Value>
    </umbracoUrlName>
  </Properties>
</Content>